Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CSPC Pharmaceutical Group ( (HK:1093) ) has issued an announcement.
CSPC Pharmaceutical Group Limited announced the on-market purchase of 3,000,000 shares as part of its restricted share award scheme, representing approximately 0.026% of the total shares in issue. This move is aimed at benefiting selected participants and reflects the company’s ongoing commitment to its share award scheme, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating within the pharmaceutical industry. It focuses on the development, manufacture, and sale of pharmaceutical products.
YTD Price Performance: 101.99%
Average Trading Volume: 171,345,986
Technical Sentiment Signal: Buy
Current Market Cap: HK$109.6B
Find detailed analytics on 1093 stock on TipRanks’ Stock Analysis page.